| Net Cash Provided by (Used in) Operating Activities |
$337,114,000 |
USD |
83% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$502,653,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,056,923,000 |
USD |
-571% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$217,156,000 |
USD |
-8993% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$753,310,000 |
USD |
213% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$95,599,000 |
USD |
91% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$44,894,000 |
USD |
-0.54% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$8,200,000 |
USD |
-66% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$269,329,000 |
USD |
103% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
1,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$5,228,928,000 |
USD |
62% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
1,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$1,166,902,000 |
USD |
23% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$685,674,000 |
USD |
297% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$249,076,000 |
USD |
29% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$159,173,000 |
USD |
46% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |